Cereve (Medtronic)

Overview

Cereve is a division of Medtronic (NYSE: MDT) focused on sleep disorder therapies and medical devices. Headquartered in Minneapolis, Minnesota, Cereve develops continuous positive airway pressure (CPAP) devices and sleep monitoring technologies for the treatment of sleep apnea and other sleep disorders.

While Cereve's primary focus is on obstructive sleep apnea (OSA), their expertise in sleep medicine positions them as a potential player in addressing sleep disorders associated with neurodegenerative diseases, including Parkinson's disease-related sleep dysfunction.

Products and Pipeline

Current Products

| Product | Indication | Status |
|---------|------------|--------|
| AirSense 11 CPAP | Sleep apnea | Marketed |
| AirCurve Bi-level | Complex sleep apnea | Marketed |
| Cereve Sleep Lab | Diagnostic equipment | Marketed |

Sleep Monitoring Capabilities

Cereve's devices incorporate advanced monitoring features that could be adapted for neurodegenerative disease applications:

• Respiratory event detection: Identifying sleep-disordered breathing patterns
• Sleep stage tracking: Monitoring REM sleep duration and quality
• Movement analysis: Detecting periodic limb movements and REM sleep without atonia

Relevance to Neurodegenerative Disease

Parkinson's Disease Sleep Disorders

Sleep disorders are among the most common non-motor symptoms in PD, affecting up to 90% of patients:

...

Overview

Cereve is a division of Medtronic (NYSE: MDT) focused on sleep disorder therapies and medical devices. Headquartered in Minneapolis, Minnesota, Cereve develops continuous positive airway pressure (CPAP) devices and sleep monitoring technologies for the treatment of sleep apnea and other sleep disorders.

While Cereve's primary focus is on obstructive sleep apnea (OSA), their expertise in sleep medicine positions them as a potential player in addressing sleep disorders associated with neurodegenerative diseases, including Parkinson's disease-related sleep dysfunction.

Products and Pipeline

Current Products

| Product | Indication | Status |
|---------|------------|--------|
| AirSense 11 CPAP | Sleep apnea | Marketed |
| AirCurve Bi-level | Complex sleep apnea | Marketed |
| Cereve Sleep Lab | Diagnostic equipment | Marketed |

Sleep Monitoring Capabilities

Cereve's devices incorporate advanced monitoring features that could be adapted for neurodegenerative disease applications:

• Respiratory event detection: Identifying sleep-disordered breathing patterns
• Sleep stage tracking: Monitoring REM sleep duration and quality
• Movement analysis: Detecting periodic limb movements and REM sleep without atonia

Relevance to Neurodegenerative Disease

Parkinson's Disease Sleep Disorders

Sleep disorders are among the most common non-motor symptoms in PD, affecting up to 90% of patients:

• REM sleep behavior disorder (RBD): Characterized by loss of REM atonia leading to dream enactment
• Sleep fragmentation: Frequent awakenings throughout the night
• Obstructive sleep apnea: More prevalent in PD patients than general population
• Nocturnal hypoventilation: Respiratory dysfunction during sleep

Potential Applications

While Cereve's current products are not specifically indicated for RBD, their technology could be adapted for:

RBD monitoring: Detecting muscle activity during REM sleep

Treatment response tracking: Monitoring effectiveness of RBD interventions

Clinical trial endpoints: Providing objective sleep metrics for PD clinical trials

Combination therapies: Integrating with pharmacological treatments for sleep disorders

Market Position

Cereve (Medtronic) is one of the leading players in the sleep therapy market:

• Market share: Top 3 in global CPAP/biPAP market
• Revenue: Part of Medtronic's Restorative Therapies Group
• Global presence: Operations in 150+ countries

Competitive Landscape

| Company | Products | Focus |
|---------|----------|-------|
| ResMed | CPAP, ASV | Sleep apnea, respiratory care |
| Philips Respironics | CPAP, BiPAP | Sleep and respiratory (recalls impacting) |
| Fisher & Paykel | CPAP, humidification | Sleep therapy |
| ImThera (Samsung) | Tongue stimulation | Sleep apnea |

Research and Development

Medtronic invests significantly in sleep therapy R&D:

• Adaptive servo-ventilation: Automatically adjusting therapy based on breathing patterns
• Remote patient monitoring: Cloud-based sleep data analytics
• AI-driven diagnostics: Machine learning for sleep disorder detection

Strategic Outlook

Cereve's potential role in neurodegenerative disease-related sleep disorders includes:

Device adaptation: Modifying existing platforms for RBD monitoring

Partnerships: Collaborating with pharmaceutical companies for combined device-drug therapies

Digital health integration: Connecting sleep devices with broader patient monitoring ecosystems

Cross-References

• [Parkinson's Disease](/diseases/parkinsons-disease)
• [REM Sleep Behavior Disorder](/mechanisms/rem-sleep-behavior-disorder-neurodegeneration-pathway)
• [PD Sleep Disorder Treatments](/companies/pd-sleep-disorder-treatments)
• [Sleep Disorders in Neurodegeneration](/therapeutics/sleep-disorders-neurodegeneration)

See Also

• [Parkinson's Disease Non-Motor Symptoms](/therapeutics/parkinsons-non-motor-symptoms)
• [Medical Device Companies](/companies/bci-landscape)

References

[Cereve Sleep Therapy Overview (2024)](https://www.medtronic.com/cereve)

[Medtronic Annual Report (2024)](https://www.medtronic.com)

[Sleep Disorders in Parkinson's Disease - Nature Reviews Neurology](https://pubmed.ncbi.nlm.nih.gov/)